Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 29 out of 100. Risk factors

Topic: Risk, prevention and care in population studies

Introduction: Excess salt intake is one of the relevant dietary determinants of elevated blood pressure and hypertension, with a direct impact on cardiovascular risk. In today's food environment, a substantial proportion of sodium comes from "hidden salt" added to processed and ultra-processed foods, which limits the effectiveness of interventions focused exclusively on the salt shaker and reinforces the need for combined strategies. The most robust scientific evidence shows that reducing sodium/salt lowers blood pressure, with a greater effect in people with hypertension and in salt-sensitive profiles. Although associations have been reported with other outcomes, such as gastric cancer, kidney stones and bone mineral balance, or cognitive decline, study findings are more heterogeneous and require cautious interpretation. Part of the current controversy arises from observational results suggesting non-linear associations and a potential modifying role of potassium, together with limitations in estimating sodium intake. Overall, the most effective approach integrates individual and population-level measures: promoting overall healthy dietary patterns, prioritizing reductions in hidden salt, using culinary strategies to preserve palatability, improving label reading, and supporting product reformulation and monitoring.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Aparicio, A., González‐Rodríguez, L. G., Cuadrado‐Soto, E., & Bermejo, L. M. (2026). Dietary sodium intake: evidence, controversies and practical recommendations. Nutrición Hospitalaria. https://doi.org/10.20960/nh.06959

Vancouver

Aparicio A, González‐Rodríguez LG, Cuadrado‐Soto E, Bermejo LM. Dietary sodium intake: evidence, controversies and practical recommendations. Nutrición Hospitalaria. 2026. doi:10.20960/nh.06959. PMID: 42377342.

BibTeX

@article{aparicio2026-42377342,
  author  = {Aparicio, Aránzazu and González‐Rodríguez, Liliana Guadalupe and Cuadrado‐Soto, Esther and Bermejo, Laura M.},
  title   = {{Dietary sodium intake: evidence, controversies and practical recommendations}},
  journal = {Nutrición Hospitalaria},
  year    = {2026},
  doi     = {10.20960/nh.06959},
  pmid    = {42377342},
  url     = {https://doi.org/10.20960/nh.06959}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

The paper states that evidence linking sodium intake to cognitive decline is mixed and should be interpreted cautiously, while the strongest evidence concerns blood pressure. It does not show that reducing salt prevents or treats Alzheimer's disease.

Study details

How this study scored 29/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record left out, no data; Institution's track record 0 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. 28 of the 96 points it could be judged on, which is 29 of 100. Total 29 of 100.28 of the 96 points we could judge = 29 of 100

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 28 of the 96 points we could judge it on, which is 29 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Nutrición Hospitalaria)
Journal's citation record 0 / 4 Nutrición Hospitalaria: journal h-index 43 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 2 year(s) since 2026
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 OpenAlex's profile for last-listed author Laura M. Bermejo holds only 7 work(s), too few to judge a track record — left out of this score
Institution's track record 0 / 3 Universidad Complutense de Madrid: institution h-index 656 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 3 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 42377342)
Free to read 2 / 2 Free to read
Points 28 / 96 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 28 of the 96 points we could judge it on is 29 out of 100.
Total 29 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Related studies in Risk factors

Also in Risk factors

356 studies in the library are filed under Risk factors with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Risk factors hub.

Similar studies

More on Risk factors

See all studies in Risk factors →